About: Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2000 (uk) مقالة علمية تنشرت ف 1 دجنبر 2000 (ary) im Dezember 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2000 (ast) scientific article published on 01 December 2000 (en)
publication date	wds:Q73456829-A809789B-A102-48DF-AEA8-A2938B127880
publication date	2000-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73456829-39164A6F-C673-4B19-BEC7-4ADA2DB619C2 wds:Q73456829-6497F6EF-E832-4C54-B55E-006E854B0A83 wds:Q73456829-A7B90034-C191-472F-9D45-B4F4659B9ED1 wds:Q73456829-EAF56648-8607-4780-89BF-2A0417229336
author name string	W Roth J Stangier C A Su G Schöndorfer
rdfs:label	Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (en) Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (nl)
skos:prefLabel	Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (en) Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (nl)
name	Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (en) Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (nl)
title	wds:Q73456829-86E1E5C4-C6FF-4603-9DFE-ECD9411F0F75
title	Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers (en)
page(s)	wds:Q73456829-5E0700C1-4E9E-4156-8AFE-ACB7C052B27D
page(s)	1355-1364
instance of	wds:Q73456829-51D12810-34D7-45C7-9DF3-45166FE0838B
instance of	scholarly article
main subject	wds:Q73456829-244FF1AC-7B7C-42C3-BCA6-167C49360EF6
main subject	pharmacokinetics
PubMed ID	wds:Q73456829-9B653890-6D78-4450-B5CE-4E5EEBB3259F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11185634
PubMed ID	11185634
published in	wds:Q73456829-3DDF612D-D23B-462F-8892-13BB71D368DE
published in	The Journal of Clinical Pharmacology
issue	wds:Q73456829-0967D3E2-291A-412A-AEC6-3197F6A78733
volume	wds:Q73456829-EC6B2381-47AE-4C40-9209-DCF3D60703F1
issue	12 Pt 1
volume	40
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73456829
is cites work of	Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan Telmisartan: a review of its use in the management of hypertension. Telmisartan: a review of its use in hypertension Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension Neurorestoration after traumatic brain injury through angiotensin II receptor blockage The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography. Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral th Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions
is cites work of	wds:Q28535089-7E87620F-2AEE-4EBA-80E7-2E3103992C5B wds:Q38829596-9D97666F-3A3A-40CE-8F55-7B44D56C7C27 wds:Q34370482-02E6C19E-C0ED-441C-B1EE-565CB7C02157 wds:Q36421051-4E2B884D-6B26-4D96-B970-399DAE6BFDCB wds:Q53160430-03971D23-A1D4-4743-BA4A-87F44BD1631D wds:Q35214553-61EE5793-6650-41B6-8AEB-D8035258643D wds:Q46883816-9003DA85-FFA3-4CE1-A70F-4BA76D247193 wds:Q37253018-0830B120-D9AA-4E4D-BBB7-3D7C6658ED62 wds:Q42351660-BB0FD17D-9318-492D-973F-4AA233977C49 wds:Q36160619-86015ADC-7A8E-4327-AFE3-37A07ED0DCE6 wds:Q36515931-81EEDB99-FCAC-4B6B-9E27-22C990CF5A77 wds:Q28610551-B18CF7ED-059C-411F-8337-A8CC8DB85EBF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software